{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:58:48Z","timestamp":1785866328767,"version":"3.56.0"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Drug-resistant tuberculosis remains a major global health threat, with an estimated 400,000 people developing rifampicin-resistant\/multidrug-resistant tuberculosis (RR\/MDR-TB) worldwide in 2023, according to the WHO Global Tuberculosis Report 2024. Immunocompromised populations, including people living with HIV, transplant recipients, patients receiving immunosuppressive therapies, and individuals with chronic metabolic diseases, are at particularly high risk of severe disease and pulmonary co-infections, resulting in delayed diagnosis, increased treatment complexity, and poor clinical outcomes. Despite advances in therapeutics, management remains constrained by fragmented diagnostic pathways, limited pathogen resolution, antimicrobial toxicity, and clinically significant drug\u2013drug interactions. Recent progress in multi-omics technologies is reshaping understanding of host\u2013pathogen dynamics in tuberculosis and co-infection states. Whole-genome sequencing enables rapid resistance prediction and transmission tracking, whereas transcriptomic, proteomic, metabolomic, and single-cell approaches are identifying biomarkers of disease severity, immune dysregulation, treatment response, and relapse risk. Parallel advances in metagenomic diagnostics and artificial intelligence-assisted imaging offer opportunities for earlier detection of mixed infections and improved clinical triage. Therapeutic paradigms are also evolving. Shorter all-oral regimens, individualized dosing strategies, therapeutic drug monitoring, and integrated antimicrobial stewardship are improving outcomes for resistant tuberculosis. Adjunctive approaches, including host-directed therapies, immunomodulation, inhaled drug delivery systems, and data-guided precision prescribing, may further enhance efficacy while reducing toxicity in vulnerable patients with co-infections. However, implementation remains uneven, and prospective evidence in immunocompromised populations is limited. Recent advances in multi-omics technologies including whole-genome sequencing, metagenomics, transcriptomics, proteomics, metabolomics, single-cell omics, and artificial intelligence-assisted diagnostics are transforming the diagnosis, biological stratification, and clinical management of DR-TB. In parallel, precision therapeutic approaches, including individualized regimen selection, therapeutic drug monitoring, host-directed therapies, and data-guided clinical decision-making, are enabling more personalized treatment strategies. This review integrates these advances into a precision medicine framework and discusses their clinical application, current limitations, and future directions for improving outcomes in immunocompromised patients with DR-TB and pulmonary co-infections.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1893416","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:55:57Z","timestamp":1785862557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-resistant tuberculosis and pulmonary co-infections in immunocompromised patients: from multi-omics to precision therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Ahong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Kashi Prefecture Second People\u2019s Hospital, Kashi","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanizaier","family":"Reheman","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Kashi Prefecture Second People\u2019s Hospital, Kashi","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Kashi Prefecture Second People\u2019s Hospital, Kashi","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moru","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Kashi Prefecture Second People\u2019s Hospital, Kashi","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilinuer","family":"Abulikemu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Kashi Prefecture Second People\u2019s Hospital, Kashi","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaizhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Traditional Medicine Hospital of Kashgar Prefecture","place":["Kashgar, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e70156","DOI":"10.1002\/puh2.70156","article-title":"Understanding global health inequality and inequity: causes, consequences, and the path toward justice in healthcare.","volume":"4","author":"Abdi","year":"2025","journal-title":"Public Health Chall"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e88204","DOI":"10.7759\/cureus.88204","article-title":"Prevalence of multidrug-resistant tuberculosis and its association with previous treatment history in adults.","volume":"17","author":"Ahmad Mughal","year":"2025","journal-title":"Cureus"},{"key":"B3","first-page":"250243","article-title":"Post-tuberculosis lung disease.","volume":"22","author":"Al-Hindawi","year":"2026","journal-title":"Breathe"},{"key":"B4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/joim.70092","article-title":"Immune endotypes in tuberculosis: keys to decoding disease complexity.","volume":"299","author":"Alipoor","year":"2026","journal-title":"J. Internal Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/tropicalmed10070190","article-title":"Risk of latent tuberculosis infection reactivation in patients treated with tumor necrosis factor antagonists: a five-year retrospective study.","volume":"10","author":"Al\u0131ravc\u0131","year":"2025","journal-title":"Trop. Med. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing.","volume":"379","author":"Allix-B\u00e9guec","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update.","volume":"74","author":"Alsultan","year":"2014","journal-title":"Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States.","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ajhp\/zxaf044","article-title":"KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: a primer on what pharmacists need to know.","volume":"82","author":"Awdishu","year":"2025","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4103\/lungindia.lungindia_291_25","article-title":"Diabetes and tuberculosis: a syndemic India cannot afford to ignore.","volume":"42","author":"Bajpai","year":"2025","journal-title":"Lung. India"},{"key":"B12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.320.7240.959\/a","article-title":"Tuberculosis is spreading in central and Eastern Europe.","volume":"320","author":"Balinska","year":"2000","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group.","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"212527","DOI":"10.7573\/dic.212527","article-title":"How to manage Pseudomonas aeruginosa infections.","volume":"7","author":"Bassetti","year":"2018","journal-title":"Drugs Context"},{"key":"B15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13063-022-06331-8","article-title":"TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II\u2013III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.","volume":"23","author":"Berry","year":"2022","journal-title":"Trials"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.34067\/KID.0000000000000545","article-title":"Cancer screening and cancer treatment in kidney transplant recipients.","volume":"360","author":"Bigotte Vieira","year":"2024","journal-title":"Kidney"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e727","DOI":"10.1093\/cid\/ciaf279","article-title":"Pulmonary tuberculosis\u2013associated chronic pulmonary Aspergillosis: urgent need to standardize reporting of prevalence studies.","volume":"81","author":"Bongomin","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/diagnostics15151909","article-title":"The molecular diagnosis of invasive fungal diseases with a focus on PCR.","volume":"15","author":"Brown","year":"2025","journal-title":"Diagnostics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00812-17","DOI":"10.1128\/mBio.00812-17","article-title":"The New Xpert MTB\/RIF ultra: improving detection of mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing.","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"},{"key":"B20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","article-title":"State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.","volume":"49","author":"Chong","year":"2021","journal-title":"Infection"},{"key":"B21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline\u2013pretomanid\u2013linezolid regimens for drug-resistant tuberculosis.","volume":"387","author":"Conradie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis.","volume":"382","author":"Conradie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing.","volume":"379","author":"Allix-B\u00e9guec","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"970408","DOI":"10.3389\/fmed.2022.970408","article-title":"Host-directed therapies in pulmonary tuberculosis: updates on anti-inflammatory drugs.","volume":"9","author":"Cubillos-Angulo","year":"2022","journal-title":"Front. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1634772","DOI":"10.3389\/fpubh.2025.1634772","article-title":"Global, regional, and national burdens of MDR-TB attributable to smoking from 1990 to 2021 with a prediction from 2022 to 2050.","volume":"13","author":"Dan","year":"2025","journal-title":"Front. Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut-lung axis.","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1612709","DOI":"10.3389\/fimmu.2025.1612709","article-title":"Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis.","volume":"16","author":"Dasan","year":"2025","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S1473-3099(21)00808-2","article-title":"25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward.","volume":"22","author":"Dean","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.","volume":"47","author":"Denning","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e171312","DOI":"10.3201\/eid2408.171312","article-title":"Case definition of chronic pulmonary aspergillosis in resource-constrained settings.","volume":"24","author":"Denning","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.","volume":"89","author":"Denning","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.","author":"Dheda","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S2213-2600(24)00300-X","article-title":"Towards shorter, safer, flexible, and more effective treatment regimens for drug-resistant tuberculosis.","volume":"12","author":"Dheda","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"H43","DOI":"10.1177\/135965350701203S06","article-title":"Special considerations and treatment of patients with HBV-HIV coinfection.","volume":"12","author":"Dieterich","year":"2007","journal-title":"Antivir. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0021-18","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection.","volume":"31","author":"Drain","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B37","volume-title":"WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment and Care [Internet].","year":"2025"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100719","DOI":"10.1016\/j.bj.2024.100719","article-title":"The epidemiology of invasive fungal infections in transplant recipients.","volume":"47","author":"Elhaj Mahmoud","year":"2024","journal-title":"Biomed. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.jctube.2025.100522","article-title":"Strengthening the global Response to Tuberculosis: insights from the 2024 WHO global TB report.","volume":"39","author":"Estaji","year":"2025","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.3390\/jcm14248646","article-title":"Integrated artificial intelligence framework for tuberculosis treatment abandonment prediction: a multi-paradigm approach.","volume":"14","author":"Filho","year":"2025","journal-title":"J. Clin. Med."},{"key":"B41","article-title":"Detection and diagnostics","volume-title":"Global Infectious Disease Surveillance and Detection: Assessing the Challenges\u2014Finding Solutions, Workshop Summary","author":"Lemon","year":"2007"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11548-025-03547-2","article-title":"AI in radiology and interventions: a structured narrative review of workflow automation, accuracy, and efficiency gains of today and what\u2019s coming.","volume":"21","author":"Friebe","year":"2026","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/CM9.0000000000002771","article-title":"Post-tuberculosis lung disease and chronic obstructive pulmonary disease.","volume":"136","author":"Gai","year":"2023","journal-title":"Chin. Med. J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection.","volume":"372","author":"Getahun","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cmi.2024.08.006","article-title":"Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges.","volume":"31","author":"Giannella","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1004603","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization.","volume":"11","author":"Gideon","year":"2015","journal-title":"PLoS Pathog."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1487518","DOI":"10.3389\/ftubr.2024.1487518","article-title":"Ending tuberculosis: challenges and opportunities.","volume":"2","author":"Gilmour","year":"2024","journal-title":"Front. Tuberc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e70077","DOI":"10.1111\/tid.70077","article-title":"Invasive fungal disease in solid organ and hematopoietic cell transplant recipients, United States.","volume":"27","author":"Gold","year":"2025","journal-title":"Transpl. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"107325","DOI":"10.1016\/j.ijid.2024.107325","article-title":"Insights from the 2024 WHO Global tuberculosis report - more comprehensive action, innovation, and investments required for achieving WHO End TB goals.","volume":"150","author":"Goletti","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","article-title":"Hospital-acquired infections in critically Ill patients with COVID-19.","volume":"160","author":"Grasselli","year":"2021","journal-title":"Chest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e02175-18","DOI":"10.1128\/AAC.02175-18","article-title":"Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.","volume":"63","author":"Gygli","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"100967","DOI":"10.1016\/j.lanmic.2024.100967","article-title":"Prevalence and clinical relevance of viraemia in viral respiratory tract infections: a systematic review.","volume":"6","author":"Hagman","year":"2025","journal-title":"Lancet Microbe"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/infdis\/jiab311","article-title":"Defining the role of cellular immune signatures in diagnostic evaluation of suspected tuberculosis.","volume":"225","author":"Halliday","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury.","volume":"156","author":"Hanania","year":"2019","journal-title":"Chest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e69068","DOI":"10.2196\/69068","article-title":"Diagnostic performance of artificial intelligence\u2013based methods for tuberculosis detection: systematic review.","volume":"27","author":"Hansun","year":"2025","journal-title":"J. Med. Internet Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.","volume":"365","author":"Havlir","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1002\/bcp.70298","article-title":"Challenges in optimizing tacrolimus therapy in patients treated with rifampin: a case series.","volume":"91","author":"Houwen","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1679691","DOI":"10.3389\/fcimb.2025.1679691","article-title":"IFN-\u03b3-Driven macrophage responses in the immunity to Mycobacterium tuberculosis and Mycobacterium leprae.","volume":"15","author":"Imran","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.2147\/IDR.S563939","article-title":"Coinfection of SARS-CoV-2 and influenza: a catastrophic coexistence.","volume":"18","author":"Jheng","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"B60","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/CM9.0000000000001948","article-title":"Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs: meta-analysis of randomized clinical trials.","volume":"135","author":"Ji","year":"2022","journal-title":"Chin. Med. J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"817","DOI":"10.22207\/JPAM.20.1.63","article-title":"Association of mycotic lung infections with multidrug-resistant tuberculosis and immunocompromised status of patients.","volume":"20","author":"Jigan","year":"2026","journal-title":"J. Pure Appl. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"100585","DOI":"10.1016\/j.ijregi.2025.100585","article-title":"Undiagnosed burden of latent tuberculosis, active tuberculosis and tuberculosis-HIV co-infections in Africa\u2014status quo, needs, priorities, and opportunities.","volume":"14","author":"Kapata","year":"2025","journal-title":"IJID Reg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis.","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/antibiotics14070700","article-title":"Evaluation of infections caused by carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in an intensive care unit: a retrospective study.","volume":"14","author":"Kerimoglu","year":"2025","journal-title":"Antibiotics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/jof8030301","article-title":"Incidence of chronic pulmonary aspergillosis in patients with suspected or confirmed NTM and TB\u2014A population-based retrospective cohort study.","volume":"8","author":"Klinting","year":"2022","journal-title":"J. Fungi"},{"key":"B66","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.jctube.2024.100480","article-title":"Tuberculosis in South Asia: a regional analysis of burden, progress, and future projections using the global burden of disease (1990\u20132021).","volume":"37","author":"Kumar","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"566608","DOI":"10.3389\/fimmu.2020.566608","article-title":"Perspective for precision medicine for tuberculosis.","volume":"11","author":"Lange","year":"2020","journal-title":"Front. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","article-title":"Management of drug-resistant tuberculosis.","volume":"394","author":"Lange","year":"2019","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis.","volume":"81","author":"Lansbury","year":"2020","journal-title":"J. Infect."},{"key":"B71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/v16040494","article-title":"Advances in antiretroviral therapy for patients with human immunodeficiency virus-associated tuberculosis.","volume":"16","author":"Le","year":"2024","journal-title":"Viruses"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e126453","DOI":"10.1172\/jci.insight.126453","article-title":"Single-cell transcriptomics\u2013based MacSpectrum reveals macrophage activation signatures in diseases.","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e00503","DOI":"10.1016\/j.plabm.2025.e00503","article-title":"Advancements in laboratory diagnostics for HIV\/MTB coinfection: integrating conventional methods with emerging technologies.","volume":"47","author":"Li","year":"2025","journal-title":"Pract. Lab. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.4049\/jimmunol.2300716","article-title":"The lung microbiome.","volume":"212","author":"Lipinksi","year":"2024","journal-title":"J. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1439472","DOI":"10.3389\/fcimb.2024.1439472","article-title":"Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients.","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.it.2011.10.003","article-title":"Neutrophils in tuberculosis: friend or foe?","volume":"33","author":"Lowe","year":"2012","journal-title":"Trends Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.2147\/IDR.S461785","article-title":"The effect of rifapentine and rifampicin on serum voriconazole levels persist for 5 days and 7 days or more after discontinuation in tuberculosis patients with chronic pulmonary aspergillosis","volume":"17","author":"Lu","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"B78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/microorganisms14020428","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE) in nosocomial infections: a systematic review of resistance, pathogenesis, and clinical management.","volume":"14","author":"Lucian-Daniel","year":"2026","journal-title":"Microorganisms"},{"key":"B79","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","article-title":"Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019.","volume":"24","author":"Lv","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1093\/cid\/ciaf150","article-title":"A systematic review of chronic pulmonary aspergillosis among patients treated for pulmonary tuberculosis.","volume":"81","author":"Madden","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/eji.201344301","article-title":"Diabetes and immunity to tuberculosis.","volume":"44","author":"Martinez","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"107849","DOI":"10.1016\/j.ijid.2025.107849","article-title":"Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination.","volume":"155","author":"Matteelli","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/diseases13060184","article-title":"Integration of AI and ML in Tuberculosis (TB) management: from diagnosis to drug discovery.","volume":"13","author":"Memon","year":"2025","journal-title":"Diseases"},{"key":"B85","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12879-025-10753-5","article-title":"Antimicrobial strategies of lower respiratory tract infections in immunocompromised patients based on metagenomic next-generation sequencing: a retrospective study.","volume":"25","author":"Meng","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"04192","DOI":"10.7189\/jogh.15.04192","article-title":"Artificial intelligence for tuberculosis control: a scoping review of applications in public health.","volume":"15","author":"Menon","year":"2025","journal-title":"J. Glob. Health"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","article-title":"A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.","volume":"50","author":"Miotto","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections.","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: foe and occasionally friend.","volume":"215","author":"Moreira-Teixeira","year":"2018","journal-title":"J. Exp. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline.","volume":"200","author":"Nahid","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fmicb.2020.00435","article-title":"Metformin as host-directed therapy for TB treatment: scoping review.","volume":"11","author":"Naicker","year":"2020","journal-title":"Front. Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2352-3018(21)00324-6","article-title":"Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps.","volume":"9","author":"Naidoo","year":"2022","journal-title":"Lancet HIV"},{"key":"B93","unstructured":"StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis. clinicaltrials.gov.\n          \n          2023"},{"key":"B94","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease.","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2213-2600(23)00389-2","article-title":"Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.","volume":"12","author":"Nyang\u2019wa","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1182\/asheducation-2003.1.438","article-title":"Infections in patients with hematological cancer: recent developments.","volume":"2003","author":"O\u2019Brien","year":"2003","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"B97","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis.","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e98453","DOI":"10.7759\/cureus.98453","article-title":"Opportunistic co-infections in pulmonary tuberculosis.","volume":"17","author":"Oliveira","year":"2025","journal-title":"Cureus"},{"key":"B99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.","volume":"190","author":"Ong","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.2253011575","article-title":"High-resolution CT quantification of bronchiectasis: clinical and functional correlation.","volume":"225","author":"Ooi","year":"2002","journal-title":"Radiology"},{"key":"B101","unstructured":"A Randomized Controlled Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine) to Promote TB Lung Function Recovery (TB-MET-NAC). clinicaltrials.gov.\n          \n          2025"},{"key":"B102","doi-asserted-by":"publisher","first-page":"E1171","DOI":"10.1503\/cmaj.180597","article-title":"Chronic pulmonary aspergillosis after pulmonary tuberculosis.","volume":"190","author":"Ortiz-Brizuela","year":"2018","journal-title":"CMAJ"},{"key":"B103","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis.","volume":"2","author":"Pai","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.5588\/ijtld.15.0926","article-title":"Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review.","volume":"20","author":"Pande","year":"2016","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jinf.2023.01.003","article-title":"Klebsiella pneumoniae infection in the paediatric population before and after the COVID-19 pandemic in Shenzhen, China.","volume":"86","author":"Patil","year":"2023","journal-title":"J. Infect."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America.","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2165\/00003495-200262150-00001","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis.","volume":"62","author":"Peloquin","year":"2002","journal-title":"Drugs"},{"key":"B109","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America.","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"CD014841","DOI":"10.1002\/14651858.CD014841.pub2","article-title":"Xpert MTB\/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.","volume":"2022","author":"Pillay","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"834013","DOI":"10.3389\/fitd.2022.834013","article-title":"Treatment of tuberculosis and the drug interactions associated with HIV-TB co-infection treatment.","volume":"3","author":"Pooranagangadevi","year":"2022","journal-title":"Front. Trop. Dis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"8766717","DOI":"10.1155\/cjid\/8766717","article-title":"Fungal infections in pediatric patients with hematologic malignancies and stem cell transplantation: impact on the upper and lower respiratory systems.","volume":"2026","author":"Pourghasem","year":"2026","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S2589-7500(21)00116-3","article-title":"Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms.","volume":"3","author":"Qin","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e4264","DOI":"10.15649\/cuidarte.4264","article-title":"Two epidemics, one patient: coinfection by SARS-CoV-2 and influenza in Colombia.","volume":"16","author":"Quintana-Ospina","year":"2025","journal-title":"Rev. Cuid"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0330426","DOI":"10.1371\/journal.pone.0330426","article-title":"A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.","volume":"20","author":"Rabagliati","year":"2025","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e17336","DOI":"10.7759\/cureus.17336","article-title":"Potential drug-drug interactions in hospitalized medical patients: data from low resource settings.","volume":"13","author":"Rashid","year":"2021","journal-title":"Cureus"},{"key":"B117","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation.","volume":"13","author":"Razonable","year":"2013","journal-title":"Am. J. Transplant."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(19)30024-8","article-title":"Building a tuberculosis-free world: the lancet commission on tuberculosis.","volume":"393","author":"Reid","year":"2019","journal-title":"Lancet"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/antibiotics12121733","article-title":"How we treat drug-susceptible pulmonary tuberculosis: a practical guide for clinicians.","volume":"12","author":"Riccardi","year":"2023","journal-title":"Antibiotics"},{"key":"B120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S2213-2600(26)00095-0","article-title":"Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial.","volume":"14","author":"Rie","year":"2026","journal-title":"Lancet Respir. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41423-021-00694-9","article-title":"Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor.","volume":"18","author":"Robert","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10096-025-05301-7","article-title":"Managing tuberculosis infection among migrants from high-incidence tuberculosis countries: challenges, strategies and recommendations.","volume":"45","author":"Rotundo","year":"2026","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"22669","DOI":"10.1038\/s41598-024-73304-z","article-title":"Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia.","volume":"14","author":"Ryu","year":"2024","journal-title":"Sci. Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ajh.27565","article-title":"Respiratory viruses in patients with hematological malignancy in boreal autumn\/winter 2023\u20132024: EPICOVIDEHA-EPIFLUEHA Report.","volume":"100","author":"Salmanton-Garc\u00eda","year":"2024","journal-title":"Am. J. Hematol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.ijtb.2025.11.013","article-title":"Predicting multi-drug resistant tuberculosis using machine learning on genomic and clinical data.","volume":"72","author":"Saxena","year":"2025","journal-title":"Indian J. Tuberc."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1111\/myc.70060","article-title":"Prevalence of chronic pulmonary aspergillosis in patients with mycobacterial and non-mycobacterial tuberculosis infection of the lung: a systematic review and meta-analysis.","volume":"68","author":"Sehgal","year":"2025","journal-title":"Mycoses"},{"key":"B127","doi-asserted-by":"publisher","first-page":"ofad177","DOI":"10.1093\/ofid\/ofad177","article-title":"At long last: short, all-oral regimens for multidrug-resistant tuberculosis in the United States.","volume":"10","author":"Sinha","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.6026\/973206300211602","article-title":"Clinical spectrum of tuberculosis among HIV infected patients in India: correlation with immunological status using CD4 counts.","volume":"21","author":"Snigdha","year":"2025","journal-title":"Bioinformation"},{"key":"B129","doi-asserted-by":"publisher","first-page":"107876","DOI":"10.1016\/j.ijid.2025.107876","article-title":"Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality.","volume":"155","author":"Sossen","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/TP.0000000000004855","article-title":"What\u2019s new: updates on cytomegalovirus in solid organ transplantation.","volume":"108","author":"Stewart","year":"2024","journal-title":"Transplantation"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e13513","DOI":"10.1111\/ctr.13513","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation.","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin. Transplant."},{"key":"B132","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12941-026-00848-5","article-title":"The impact of the timing of mNGS-guided antibiotic adjustment on clinical outcomes in ICU patients with severe community-acquired pneumonia: a retrospective study.","volume":"25","author":"Sun","year":"2026","journal-title":"Ann. Clin. Microbiol. Antimicrob"},{"key":"B133","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.jctube.2025.100510","article-title":"The persistent threat of tuberculosis - Why ending TB remains elusive?","volume":"38","author":"Suvvari","year":"2025","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(16)00048-5","article-title":"Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis.","volume":"4","author":"Sweeney","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2001398","DOI":"10.1183\/13993003.01398-2020","article-title":"Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.","volume":"56","author":"Tadolini","year":"2020","journal-title":"Eur. Respir. J."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s12879-025-11566-2","article-title":"Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning.","volume":"25","author":"Tan","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0140-6736(16)30578-5","article-title":"HIV and tuberculosis in prisons in sub-Saharan Africa.","volume":"388","author":"Telisinghe","year":"2016","journal-title":"Lancet"},{"key":"B139","unstructured":"A Ph2 Randomized Trial to Evaluate the Safety Preliminary Efficacy and Biomarker Response of Host Directed Therapies Added to Rifabutin-modified Standard Therapy in Adults With Drug-Sensitive Smear-Positive Pulmonary TB.\n          \n          2019"},{"key":"B140","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1473-3099(25)00485-2","article-title":"New advances for drug-resistant tuberculosis.","volume":"25","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1108155","DOI":"10.3389\/fcimb.2023.1108155","article-title":"Advancing personalized medicine for tuberculosis through the application of immune profiling.","volume":"13","author":"Thu","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e50222","DOI":"10.7759\/cureus.50222","article-title":"Multi-drug resistance tuberculosis (MDR-TB) challenges in India: a review.","volume":"15","author":"Vishwakarma","year":"2023","journal-title":"Cureus"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e0332807","DOI":"10.1371\/journal.pone.0332807","article-title":"Clinical characteristics, risk factors and outcome of critically ill immunocompromised patients with bloodstream infections and sepsis.","volume":"20","author":"Vonineng","year":"2025","journal-title":"PLoS One"},{"key":"B146","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri3813","article-title":"Advancing host-directed therapy for tuberculosis.","volume":"15","author":"Wallis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","article-title":"Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.","volume":"18","author":"Walzl","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B148","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(24)00069-0","article-title":"The hidden threat of subclinical tuberculosis.","volume":"24","author":"Wei","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion.","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jof4040127","article-title":"Therapy and management of Pneumocystis jirovecii infection.","volume":"4","author":"White","year":"2018","journal-title":"J. Fungi"},{"key":"B151","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/pathogens11040389","article-title":"Diagnostic advances in childhood tuberculosis\u2014improving specimen collection and yield of microbiological diagnosis for intrathoracic tuberculosis.","volume":"11","author":"Wobudeya","year":"2022","journal-title":"Pathogens"},{"key":"B152","unstructured":"WHO Operational Handbook on Tuberculosis: Module 4: Treatment: Drug-Resistant Tuberculosis Treatment.\n          \n          2020"},{"key":"B153","volume-title":"WHO Consolidated Guidelines on Tuberculosis.","year":"2024"},{"key":"B154","unstructured":"Global Tuberculosis Report 2024 \u2013 Fundacio Unitat D\u2019investigaci\u00f3 En Tuberculosis A Barcelona.\n          \n          2025"},{"key":"B155","volume-title":"WHO Operational Handbook on Tuberculosis: Module 3: Diagnosis: Rapid Diagnostics for Tuberculosis Detection, 3rd ed.","year":"2026"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(22)01938-9","article-title":"WHO\u2019s therapeutics and COVID-19 living guideline on mAbs needs to be reassessed.","volume":"400","author":"Wu","year":"2023","journal-title":"Lancet"},{"key":"B157","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mib.2018.04.004","article-title":"Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria.","volume":"45","author":"Wyres","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1602636","DOI":"10.3389\/fcimb.2025.1602636","article-title":"Diagnostic value of metagenomic next generation sequencing of bronchoalveolar lavage fluid in immunocompromised patients with pneumonia.","volume":"15","author":"Xin","year":"2025","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12877-025-06934-1","article-title":"Tuberculosis in older adults (\u226565 years): global trends, sex differences, and regional variations, 2000\u20132023.","volume":"26","author":"Yayan","year":"2026","journal-title":"BMC Geriatr."},{"key":"B160","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1017\/S0950268825100095","article-title":"Trend and forecast analysis of the changing disease burden of tuberculosis in China, 1990-2021.","volume":"153","author":"Zhang","year":"2025","journal-title":"Epidemiol. Infect."},{"key":"B161","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41390-025-03917-1","article-title":"Global burden of multidrug-resistant tuberculosis in children and adolescents.","volume":"98","author":"Zhong","year":"2025","journal-title":"Pediatr. Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.21037\/jtd-2025-1296","article-title":"Pathogen distribution and prognostic risk factors in respiratory intensive care unit (RICU) patients of a large general hospital before and after COVID-19 pandemic.","volume":"17","author":"Zhu","year":"2025","journal-title":"J. Thorac. Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1002\/mco2.419","article-title":"Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention.","volume":"5","author":"Zhuang","year":"2024","journal-title":"MedComm"},{"key":"B164","doi-asserted-by":"publisher","first-page":"38801","DOI":"10.1038\/s41598-025-22780-y","article-title":"Prevalence of comorbidities and their impact on prognosis among patients with rifampicin-resistant tuberculosis: a multicenter retrospective cohort study in China.","volume":"15","author":"Zou","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1893416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:56:00Z","timestamp":1785862560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1893416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":164,"alternative-id":["10.3389\/fmicb.2026.1893416"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1893416","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1893416"}}